PLUR:NASDAQ
Pluri Inc
$0.93
arrow_upward
+0.01%(+0.00010) 1D
Oct 19, 11:49:37 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
$0.90
High
$0.93
Low
$0.90
Mkt. cap
11.48M
Avg. vol.
15.85K
Volume
3.00K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.69
Shares outstanding
12.61M
No. of employees
103
Open
$0.90
High
$0.93
Low
$0.90
Mkt. cap
11.48M
Avg. vol.
15.85K
Volume
3.00K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.69
Shares outstanding
12.61M
No. of employees
103
News stories
From web sources and news partners
24/7 Wall St.
·
7 minutes ago
S&P 500 Climbs to 7,721 at Midday, Led by a Tech-Heavy Surge
Yahoo Finance
·
27 minutes ago
Oppenheimer Lifts S&P 500 Full-Year Earnings Growth Outlook
Cryptonews.net
·
38 minutes ago
S&P 500 price prediction on Black Monday’s 39th anniversary
TradingView
·
2 hours ago
The Dow Jones Index Opens 0.08% Lower
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees103
FoundedMay 11, 2001
HeadquartersHaifa, Haifa District, Israel
SectorBiotechnology
Websitepluri-biotech.com